| Management target | Revenue 10.0% FY27 |
|---|
| Revenue growth | 12% YoY decline in Q1 FY27 consolidated revenue. |
|---|---|
| Margins | Consolidated EBITDA margin improved to 18% from 10.9% YoY. |
| Order book | Starting to receive trial orders for new Nano fertilizer products. |
| Demand visibility | Soft demand currently; buyers cautious due to macroeconomic uncertainties. |
| Management confidence | Very optimistic on long-term growth in Crop Protection and Nutrition. |
Growth
Revenue down 12% YoY; EBITDA grew 46% to INR97.9cr; PAT surged 280%. Standalone revenue was INR523cr.
Outlook
Targeting double-digit growth in Crop Protection; INR2,500-3,000cr peak revenue potential at optimum utilization; debt reduction continues.
Risks
Subdued demand in Latin America; Titanium Dioxide plant suspended due to high raw material (sulfur) costs.
Last quarter's promises, checked
Delivered
- Guided 15-17% Crop Protection EBITDA margin → delivered 18% (= BEAT)
- Guided routine capex INR35-40cr → delivered debt reduction focus (= BEAT)
- Guided better Pigment profitability vs FY26 (3.3%) → delivered 25% revenue share with margin focus (= BEAT)
Partly delivered
- Guided Nano fertilizer commercialization in Kharif season → delivered trial orders received (= PARTIAL)
Missed
- Guided double-digit Crop Protection topline growth → delivered 12% consolidated revenue decline (= MISS)
Earnings Call Transcript filed with NSE, NSE: MOL. Summary written with AI assistance from the document.
Meghmani Organics Ltd: key numbers
- Share price
- ₹58.52
- Market cap
- ₹1,488 Cr
- Revenue (annual)
- ₹2,174 Cr
- Net profit (annual)
- ₹28.74 Cr
- P/E (TTM)
- 23.2×Sector 37.5×
- Promoter holding
- 48.95%+0.00% QoQ
- FII holding
- 0.91%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Meghmani Organics Ltd
All →Meghmani Organics Annual General Meeting
Meghmani Organics Limited held its 7th Annual General Meeting on September 8, 2026. The meeting concluded successfully with all items of business transacted as proposed.
Meghmani Organics Investor Presentation: Key Takeaways
Meghmani Organics reported Q1 FY27 consolidated revenue of ₹542.8 Cr, down 12% YoY, while EBITDA grew 46% to ₹97.9 Cr. Performance was driven by improved product mix despite macroeconomic uncertainties.
Meghmani Organics Q1 FY27 Results: Net Profit ₹48.2 Cr, Up 279.5% YoY
Meghmani Organics Ltd reported revenue from operations of ₹542.8 Cr (-11.5% YoY) and net profit of ₹48.2 Cr (+279.5% YoY) for Q1 FY27.
- Key figure
- Net profit ₹48.2 Cr · +279.5% YoY
Meghmani Organics Earnings Call: Key Takeaways
Meghmani Organics reported FY26 standalone revenue of ₹2,091cr (up 4% YoY) and EBITDA of ₹228.7cr (up 27% YoY). Strategy focuses on Brazil expansion and Nano-fertilizer growth.
Meghmani Organics Earnings Call: Key Takeaways
Meghmani Organics reported FY26 consolidated revenue of ₹2,174 Cr, up 5% YoY, with PAT at ₹28.7 Cr. The company is pivoting towards high-margin Crop Nutrition (Nano Urea) and Titanium Dioxide segments.
Meghmani Organics Q4 FY26 Results: Net Profit ₹8 Cr, Down 59.6% YoY
Meghmani Organics Ltd reported revenue from operations of ₹474.3 Cr (-14.3% YoY) and net profit of ₹8 Cr (-59.6% YoY) for Q4 FY26.
- Key figure
- Net profit ₹8 Cr · -59.6% YoY